These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27892456)

  • 1. IL-12 protects from psoriasiform skin inflammation.
    Kulig P; Musiol S; Freiberger SN; Schreiner B; Gyülveszi G; Russo G; Pantelyushin S; Kishihara K; Alessandrini F; Kündig T; Sallusto F; Hofbauer GF; Haak S; Becher B
    Nat Commun; 2016 Nov; 7():13466. PubMed ID: 27892456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation.
    Zwicky P; Ingelfinger F; Silva de Melo BM; Ruchti F; Schärli S; Puertas N; Lutz M; Phan TS; Kündig TM; Levesque MP; Maul JT; Schlapbach C; LeibundGut-Landmann S; Mundt S; Becher B
    Sci Immunol; 2021 Oct; 6(64):eabg9012. PubMed ID: 34678045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.
    Palombo R; Savini I; Avigliano L; Madonna S; Cavani A; Albanesi C; Mauriello A; Melino G; Terrinoni A
    Cell Death Dis; 2016 Aug; 7(8):e2344. PubMed ID: 27537526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IL-12/IL-23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod-induced psoriasis-like dermatitis.
    Takahashi T; Koga Y; Kainoh M
    Eur J Pharmacol; 2018 Jun; 828():26-30. PubMed ID: 29544684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells.
    Byamba D; Kim DY; Kim DS; Kim TG; Jee H; Kim SH; Park TY; Yang SH; Lee SK; Lee MG
    Exp Dermatol; 2014 Jul; 23(7):492-6. PubMed ID: 24824846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T Cells.
    Han Y; Mora J; Huard A; da Silva P; Wiechmann S; Putyrski M; Schuster C; Elwakeel E; Lang G; Scholz A; Scholz T; Schmid T; de Bruin N; Billuart P; Sala C; Burkhardt H; Parnham MJ; Ernst A; Brüne B; Weigert A
    Cell Rep; 2019 Apr; 27(3):835-846.e5. PubMed ID: 30995480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice.
    Van Belle AB; de Heusch M; Lemaire MM; Hendrickx E; Warnier G; Dunussi-Joannopoulos K; Fouser LA; Renauld JC; Dumoutier L
    J Immunol; 2012 Jan; 188(1):462-9. PubMed ID: 22131335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A9 Drives the Chronification of Psoriasiform Inflammation by Inducing IL-23/Type 3 Immunity.
    Silva de Melo BM; Veras FP; Zwicky P; Lima D; Ingelfinger F; Martins TV; da Silva Prado D; Schärli S; Publio G; Hiroki CH; Melo PH; Saraiva A; Norbiato T; Lima L; Ryffel B; Vogl T; Roth J; Waisman A; Nakaya HI; da Silva Souza C; Cunha FQ; Cunha TM; Becher B; Alves-Filho JC
    J Invest Dermatol; 2023 Sep; 143(9):1678-1688.e8. PubMed ID: 36921684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
    Mellett M; Meier B; Mohanan D; Schairer R; Cheng P; Satoh TK; Kiefer B; Ospelt C; Nobbe S; Thome M; Contassot E; French LE
    J Invest Dermatol; 2018 Sep; 138(9):2010-2023. PubMed ID: 29689250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation.
    Martin JC; Wolk K; Bériou G; Abidi A; Witte-Händel E; Louvet C; Kokolakis G; Drujont L; Dumoutier L; Renauld JC; Sabat R; Josien R
    J Immunol; 2017 May; 198(9):3671-3678. PubMed ID: 28356382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6 regulates psoriasiform inflammation-associated thrombosis.
    Wang Y; Golden JB; Fritz Y; Zhang X; Diaconu D; Camhi MI; Gao H; Dawes SM; Xing X; Ganesh SK; Gudjonsson JE; Simon DI; McCormick TS; Ward NL
    JCI Insight; 2016 Dec; 1(20):e89384. PubMed ID: 27942589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
    Ishizaki M; Muromoto R; Akimoto T; Sekine Y; Kon S; Diwan M; Maeda H; Togi S; Shimoda K; Oritani K; Matsuda T
    Int Immunol; 2014 May; 26(5):257-67. PubMed ID: 24345760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
    Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
    J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of interleukin-23 (p19/p40) and interleukin-12 (p35/p40) in psoriasis skin.
    Chen X; Tan Z; Yue Q; Liu H; Liu Z; Li J
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):750-2. PubMed ID: 17357509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of sleep deprivation at different timing of psoriasiform process on skin inflammation.
    Yang H; Li X; Zhang L; Xue F; Zheng J
    Biochem Biophys Res Commun; 2019 May; 513(2):452-459. PubMed ID: 30967262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17-Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin.
    Campbell JJ; Ebsworth K; Ertl LS; McMahon JP; Newland D; Wang Y; Liu S; Miao Z; Dang T; Zhang P; Charo IF; Singh R; Schall TJ
    J Immunol; 2017 Nov; 199(9):3129-3136. PubMed ID: 28972090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases.
    Teng MW; Bowman EP; McElwee JJ; Smyth MJ; Casanova JL; Cooper AM; Cua DJ
    Nat Med; 2015 Jul; 21(7):719-29. PubMed ID: 26121196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
    Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
    Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
    Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
    Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Al-Harbi MM; Almukhlafi TS
    Cell Signal; 2017 May; 33():59-68. PubMed ID: 28212864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.